Neuronetics Inc (Neuronetics) is a medical technology company that develops non-invasive therapies for psychiatric and neurological disorders. In addition, Neuronetics also offers services such as clinical training, patient education, reimbursement support, and practice support. It conducts research and clinical trials for the clinical drugs. The company offers NeuroStar which is an unique form of TMS which helps patients in dealing with the symptoms of depression. The company has adopted a cloud based management system called HIPAA-compliant TrakStar, which collects all treatment related data. It conducts studies on understanding the response in patients suffering from bipolar depression and post-traumatic stress disorder. Neuronetics is headquartered in Malvern, Pennsylvania, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Neuronetics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Neuronetics Inc Company Overview
- Neuronetics Inc Company Snapshot
- Neuronetics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Neuronetics Inc - Pipeline Analysis Overview
- Neuronetics Inc - Key Facts
- Neuronetics Inc - Major Products and Services
- Neuronetics Inc Pipeline Products by Development Stage
- Neuronetics Inc Pipeline Products Overview
- Model 2100 TMS Therapy System
- Model 2100 TMS Therapy System Product Overview
- NeuroSite Coil Placement Accessory
- NeuroSite Coil Placement Accessory Product Overview
- NeuroStar TMS Therapy System - Addiction
- NeuroStar TMS Therapy System - Addiction Product Overview
- NeuroStar TMS Therapy System - Bipolar Depression
- NeuroStar TMS Therapy System - Bipolar Depression Product Overview
- NeuroStar TMS Therapy System - Pain
- NeuroStar TMS Therapy System - Pain Product Overview
- NeuroStar TMS Therapy System - PTSD
- NeuroStar TMS Therapy System - PTSD Product Overview
- NeuroStar TMS Therapy System - Schizophrenia
- NeuroStar TMS Therapy System - Schizophrenia Product Overview
- NeuroStar TMS Therapy System - TBI
- NeuroStar TMS Therapy System - TBI Product Overview
- NeuroStar TMS Therapy System - Tinnitus
- NeuroStar TMS Therapy System - Tinnitus Product Overview
- NeuroStar XPLOR
- NeuroStar XPLOR Product Overview
- Neuronetics Inc - Key Competitors
- Neuronetics Inc - Key Employees
- Neuronetics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Neuronetics Inc, Recent Developments
- Mar 25, 2024: NeuroStar Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
- Feb 12, 2024: Neuronetics Launches Latest Evolution in its TrakStar Patient Data Management System
- Feb 06, 2024: Neurostar TMS Patient Access Expands Through Lucet Health Policy Update
- Dec 26, 2023: Neuronetics Receives an Additional 510(K) Clearance For NeuroStar Advanced Therapy System
- Dec 04, 2023: NeuroStar TMS Receives Expanded Regulatory Approval in Japan
- Nov 13, 2023: NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
- Nov 09, 2023: Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
- Oct 16, 2023: Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
- Sep 12, 2023: In Recognition of Suicide Prevention Month, Neurostar Voices Portal Amplifies Stories of Real People Beating Depression
- Aug 14, 2023: Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar Platform
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Neuronetics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Neuronetics Inc Pipeline Products by Equipment Type
- Neuronetics Inc Pipeline Products by Indication
- Neuronetics Inc, Key Facts
- Neuronetics Inc, Major Products and Services
- Neuronetics Inc Number of Pipeline Products by Development Stage
- Neuronetics Inc Pipeline Products Summary by Development Stage
- Model 2100 TMS Therapy System - Product Status
- Model 2100 TMS Therapy System - Product Description
- NeuroSite Coil Placement Accessory - Product Status
- NeuroSite Coil Placement Accessory - Product Description
- NeuroStar TMS Therapy System - Addiction - Product Status
- NeuroStar TMS Therapy System - Addiction - Product Description
- NeuroStar TMS Therapy System - Bipolar Depression - Product Status
- NeuroStar TMS Therapy System - Bipolar Depression - Product Description
- NeuroStar TMS Therapy System - Pain - Product Status
- NeuroStar TMS Therapy System - Pain - Product Description
- NeuroStar TMS Therapy System - PTSD - Product Status
- NeuroStar TMS Therapy System - PTSD - Product Description
- NeuroStar TMS Therapy System - Schizophrenia - Product Status
- NeuroStar TMS Therapy System - Schizophrenia - Product Description
- NeuroStar TMS Therapy System - TBI - Product Status
- NeuroStar TMS Therapy System - TBI - Product Description
- NeuroStar TMS Therapy System - Tinnitus - Product Status
- NeuroStar TMS Therapy System - Tinnitus - Product Description
- NeuroStar XPLOR - Product Status
- NeuroStar XPLOR - Product Description
- Neuronetics Inc, Key Employees
- Glossary
- Neuronetics Inc Pipeline Products by Equipment Type
- Neuronetics Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Nexstim Plc
- Infinite Biomedical Technologies LLC
- The Magstim Co Ltd
- Brainsway Ltd
- Cala Health Inc
- Allevia Health Inc
- Biowave Corp
